跳至主要内容
临床试验/NCT04682574
NCT04682574已完成不适用

Effects of Mega Dose Vitamin C in Critically Ill COVID-19 Patients: A Randomized Control Trial

University of Lahore1 个研究点 分布在 1 个国家目标入组 278 人开始时间: 2020年11月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
278
试验地点
1
主要终点
Partial pressure of Oxygen in arterial blood to fraction of inspired Oxygen (P/F ratio)

研究概览

简要总结

Vitamin C (ascorbic acid) is a water-soluble vitamin having anti-inflammatory, immunomodulatory, anti-oxidative, antithrombotic and antiviral properties. Considering these effects vitamin C should have beneficial impact in patients suffering from sepsis and acute respiratory distress syndrome (ARDS). The current study is designed to assess the beneficial effects of Vitamin C in COVID-19 infected patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • critically ill patients admitted in ICU

排除标准

  • allergic to Vitamin C didnt given the consent

研究组 & 干预措施

vitamin C

Active Comparator

The dose would be 30 grams a day (10 grams TDS) for 3 days with standard treatment

干预措施: Vitamin C (Drug)

结局指标

主要结局

Partial pressure of Oxygen in arterial blood to fraction of inspired Oxygen (P/F ratio)

时间窗: 1 and 4th day

Survival analysis

时间窗: 28 days follow up

次要结局

  • Length of Hospital stay(Admission to discharge)
  • Need for intubation(28 days)
  • Inflammatory markers(before the start of treatment (day 1) and on day 4)
  • APACHE II score(before the start of treatment (day 1) and on day 4)

研究者

发起方
University of Lahore
申办方类型
Other
责任方
Principal Investigator
主要研究者

Muhammad Mansoor Hafeez

Doctor

University of Lahore

研究点 (1)

Loading locations...

相似试验